Search - tctmd.com

Displaying 141 - 160 of 245

Sort: Relevancy | Date

News Features

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Michael O'Riordan

January 25, 2016

News Daily News

Low Serum Magnesium Tied to Cardiovascular Mortality, but Mechanisms Murky

Todd Neale

January 24, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

没有牙齿的研究：STABILITY 分析支持牙周病与心血管疾病之间存在关联

Shelley Wood

December 22, 2015

News Daily News

This Study Has No Teeth: STABILITY Analysis Strengthens Link Between Periodontal, CV Disease

Shelley Wood

December 22, 2015

News Daily News

Estudio sobre la Pérdida de Dientes: Un Análisis del STABILITY Confirma el Nexo existente entre Enfermedad Periodontal y CV

Shelley Wood

December 22, 2015

News Daily News

NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication

Michael O'Riordan

December 08, 2015

News Industry News

New Publication Featuring GlycoMark® Test Highlights Association of Hyperglycemic Excursions With Cardiovascular Outcomes And Mortality

November 17, 2015

Presentation

Rotational and Orbital Coronary Atherectomy: What technique should be used?

Presenter: Cesar E. Mendoza

October 29, 2015

News Daily News

Hybrid Imaging Approach Offers High Discriminatory Ability for Vulnerable Coronary Plaques

L.A. McKeown

October 13, 2015

News Industry News

Lilly to Discontinue Development of Evacetrapib for High-Risk Atherosclerotic Cardiovascular Disease

October 12, 2015

News Industry News

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

September 28, 2015

News Industry News

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)

September 11, 2015

News Industry News

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

August 31, 2015

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Daily News

新型反义抑制剂能够降低高甘油三酯水平

August 13, 2015

News Daily News

Un Nuevo Inhibidor Antisentido Reduce los Niveles Altos de Triglicéridos

August 13, 2015

News Daily News

Novel Antisense Inhibitor Cuts High Triglyceride Levels

August 13, 2015

News Industry News

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

July 28, 2015

News Industry News

Lilly Provides Update on Evacetrapib Phase 3 Trial

July 27, 2015

Advertisement

PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data

Low Serum Magnesium Tied to Cardiovascular Mortality, but Mechanisms Murky

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

没有牙齿的研究：STABILITY 分析支持牙周病与心血管疾病之间存在关联

This Study Has No Teeth: STABILITY Analysis Strengthens Link Between Periodontal, CV Disease

Estudio sobre la Pérdida de Dientes: Un Análisis del STABILITY Confirma el Nexo existente entre Enfermedad Periodontal y CV

NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication

New Publication Featuring GlycoMark® Test Highlights Association of Hyperglycemic Excursions With Cardiovascular Outcomes And Mortality

Rotational and Orbital Coronary Atherectomy: What technique should be used?

Hybrid Imaging Approach Offers High Discriminatory Ability for Vulnerable Coronary Plaques

Lilly to Discontinue Development of Evacetrapib for High-Risk Atherosclerotic Cardiovascular Disease

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

新型反义抑制剂能够降低高甘油三酯水平

Un Nuevo Inhibidor Antisentido Reduce los Niveles Altos de Triglicéridos

Novel Antisense Inhibitor Cuts High Triglyceride Levels

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

Lilly Provides Update on Evacetrapib Phase 3 Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content